Evidence map›Paper›PMID 28075174›Full record

ArticleAIDS research and human retroviruses2017

Analysis of SIVmac Envelope-Specific Antibodies Selected Through Phage Display.

Sergio Ita, Mayara R Agostinho, Katherine Sullivan, Seung Yub Han, Rana Akleh, Welkin E Johnson, Ismael Ben F Fofana

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sergio Ita1 Biology Department, Boston College , Chestnut Hill, Massachusetts.
Mayara R Agostinho1 Biology Department, Boston College , Chestnut Hill, Massachusetts.
Katherine Sullivan1 Biology Department, Boston College , Chestnut Hill, Massachusetts.
Seung Yub Han1 Biology Department, Boston College , Chestnut Hill, Massachusetts.
Rana Akleh1 Biology Department, Boston College , Chestnut Hill, Massachusetts.
Welkin E Johnson1 Biology Department, Boston College , Chestnut Hill, Massachusetts.
Ismael Ben F Fofana1 Biology Department, Boston College , Chestnut Hill, Massachusetts.
Boston College · US

Funding

UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
Cross-Species transmission and adaptation of primate lentivirusesR01AI083118 · NIAID · HARVARD MEDICAL SCHOOL · PI JOHNSON, WELKIN E · 2009 to 2019
$4.0M
NIAID NIH HHS R01 AI083118NIGMS NIH HHS K12 GM068524
6 · The paper itself

Abstract

We have constructed a single chain fragment variable (scFv) phage display library from a simian immunodeficiency virus (SIV)-infected rhesus macaque that developed unusually high-titer neutralizing antibody responses against tier-3, neutralization-resistant SIVmac239. The library was screened using trimeric (gp140) and monomeric (gp120) forms of the SIVmac239 envelope (Env) glycoprotein. We also cloned variable-heavy and variable-light (VH-VL) antibody fragments from seven previously described rhesus macaque B-cell lines (BLCLs) that produce SIV gp120-specific monoclonal antibodies (mAbs). Thirty-two gp140-specific mAbs were selected along with 20 gp120-specific ones. gp120-specific mAbs were only from the VH4 family, while gp41-specific mAbs were primarily from VH1, followed by VH4 and VH3. Rhesus macaque BLCL-derived mAbs belonged primarily to the VH4 family of antibodies followed by VH3 and a smaller number of VH1s. A preferential VH combination with Vλ light chain was observed with phage display-selected SIV Env-specific mAbs (gp120 and gp140), but not with BLCL-derived antibodies or the unpanned library. None of the tested antibodies had detectable neutralizing activity against tier-3 SIVmac239. The majority of gp120-specifc mAbs potently neutralized tier-1 SIVmac316 with 50% inhibitory concentration (IC50) values below 1 μg/ml. For gp140-specific antibodies, which were all specific for the gp41-subunit, 2 out of 11 tested neutralized SIVmac316 (IC50 of 7 and 5 μg/ml, respectively). These data suggest an order of preferential VH segment usage for SIV-specific antibodies in rhesus macaques. These antibodies will be useful in assessing the contribution of non-neutralizing antibodies to inhibition of SIV infection in vitro and in vivo.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralInhibitory Concentration 50Macaca mulattaMass ScreeningNeutralization TestsPeptide LibrarySimian Immunodeficiency VirusSingle-Chain AntibodiesViral Envelope ProteinsAntibodies, NeutralizingAntibodies, ViralPeptide LibrarySingle-Chain AntibodiesViral Envelope Proteinsantibodiesenvelopephage displaySIVVH usage

Identifiers

PMID28075174
PMCPMC5749048
OpenAlexW2575002256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.